Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT06380816

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

This clinical trial is looking at UCB4594. This is the first time the drug is being tested in humans. UCB4594 is a type of drug called a monoclonal antibody. It…

United Kingdom167 participantsStarted 2024-07-09

Treatment: UCB4594

All recent trials (3 shown)

Active — Not RecruitingPhase 2

NCT06271837

A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumo…

This is an open-label, multicenter, Phase II study to evaluate the efficacy and safety of trastuzumab deruxtecan as monotherapy or in combination with anti-canc…

China127 participantsStarted 2024-02-22

Treatment: Trastuzumab deruxtecan, Bevacizumab

CompletedPhase 1

NCT03752398

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

This is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb23104, to describe safety and tolerability, to assess PK…

United States198 participantsStarted 2019-05-01

Treatment: XmAb®23104, Yervoy® (ipilimumab)